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Dietary fat quality impacts genome-wide DNA
methylation patterns in a cross-sectional study
of Greek preadolescents
Sarah Voisin*,1,4, Markus S Alme´n1,4, George Moschonis2, George P Chrousos3, Yannis Manios2
and Helgi B Schio¨th1
The type and the amount of dietary fat have a significant influence on the metabolic pathways involved in the development
of obesity, metabolic syndrome, diabetes type 2 and cardiovascular diseases. However, it is unknown to what extent this
modulation is achieved through DNA methylation. We assessed the effects of cholesterol intake, the proportion of energy intake
derived from fat, the ratio of polyunsaturated fatty acids (PUFA) to saturated fatty acids (SFA), the ratio of monounsaturated
fatty acids (MUFA) to SFA, and the ratio of MUFAþPUFA to SFA on genome-wide DNA methylation patterns in normal-weight
and obese children. We determined the genome-wide methylation profile in the blood of 69 Greek preadolescents (B10 years
old) as well as their dietary intake for two consecutive weekdays and one weekend day. The methylation levels of one CpG
island shore and four sites were significantly correlated with total fat intake. The methylation levels of 2 islands, 11 island
shores and 16 sites were significantly correlated with PUFA/SFA; of 9 islands, 26 island shores and 158 sites with MUFA/SFA;
and of 10 islands, 40 island shores and 130 sites with (MUFAþPUFA)/SFA. We found significant gene enrichment in 34
pathways for PUFA/SFA, including the leptin pathway, and a significant enrichment in 5 pathways for (MUFAþPUFA)/SFA.
Our results suggest that specific changes in DNA methylation may have an important role in the mechanisms involved in the
physiological responses to different types of dietary fat.
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INTRODUCTION
According to the World Health Organization1, worldwide obesity has
nearly doubled since 1980, resulting in an increase in cardiovascular
diseases and diabetes type 2. One of the possible causes to this
negative development is the increase of consumption of energy-dense
foods that are high in fat. Dietary guidelines do not only recommend
to eat a moderate amount of fat, but they also recommend to
consume the right type of fat.2 Fatty acids include saturated
fatty acids (SFA), monounsaturated fatty acids (MUFA) or
polyunsaturated fatty acids (PUFA), and their structural differences
explain why they have different biological effects.3 Consuming PUFA
or MUFA instead of SFA is known to improve the blood lipid profile.4
Moreover, consumption of SFA in place of MUFA may worsen
glucose-insulin homeostasis.5 Finally, replacing SFA with PUFA has
been reported to lower coronary heart disease risk.6
Some of the effects of the qualitative and quantitative aspects
of fat intake have been imputed to a modification of the transcription
of key genes involved in pathways related to lipid and glucose
metabolism, and/or inflammation.7 The regulation of gene
expression can be achieved by mechanisms other than changes in
the nucleotide sequence, namely epigenetic processes. Such processes
are responsible for the establishment, maintenance, and reversal
of metastable transcriptional states.8 One major example of such
processes is the methylation of cytosine, usually at CpG dinucleotides,
called DNA methylation. Regions rich in CpGs are called ‘CpG
islands’ and are mostly unmethylated when located in the promoter
of active genes. Conversely, methylated promoters are associated with
reduced gene expression.9
Five studies have investigated the link between DNA methylation
and fat intake in humans, but the methylation assays in those studies
were limited to only few key genes. One study found a significantly
higher methylation in the peroxisome proliferator-activated receptor
coactivator-1 gene (PPARGC1A) in high-fat overfed men.10 Another
study found that the clock circadian regulator gene (CLOCK)
methylation was negatively associated with MUFA intake, but
positively associated with PUFA intake.11 A third study showed that
higher n-6 PUFA intake was associated with lower methylation in the
promoter of tumor necrosis factor-a (TNFa).12 A fourth study found
no significant correlation between a diet rich in fat and sucrose, and
methylation of hydroxyacyl-coenzyme A dehydrogenase (HADH) and
glucokinase (GCK) genes.13 The fifth paper reported a lack of
correlation between four diets enriched in different types of fat and
the methylation levels of leptin (LEP), leptin receptor (LEPR), and
pro-opiomelanocortin (POMC) genes.14
Here we explore the genome-wide DNA methylation profiles of
Greek preadolescents with respect to parameters related to dietary fat
quantity, and dietary fat quality. To our knowledge, this is the first
time that parameters related to both quantitative and qualitative
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aspects of fat intake with respect to DNA methylation are investigated
at a genome-wide scale. Moreover, no such studies have been
performed in children.
MATERIALS AND METHODS
Genome-wide changes of DNA methylation pattern associated with parameters
related to fat intake were assessed. Two variables related to dietary fat quantity
(proportion of energy intake derived from fat, cholesterol intake) and three
related to dietary fat quality (MUFA/SFA, PUFA/SFA and (MUFAþPUFA)/
SFA) were analyzed. A linear model that explains the methylation level for
each CpG site/island corrected for gender, weight category, Tanner stage
(an estimation of physical development), and white blood cell count was
utilized. The ratios between the unsaturated and saturated fatty acid intakes
were preferred to their individual values, as they have been reported to have
antagonistic effects. A higher fatty acids ratio would account for a ‘healthier’
fatty acid intake profile, while a lower ratio would account for an ‘unhealthier’
fatty acid intake profile.
Ethics
All participants and their guardians gave informed written consent and the
study was approved by the Greek Ministry of National Education (7055/C7-
Athens, 19-01-2007) and the Ethical Committee of Harokopio University
(16/ Athens, 19-12-2006).
Subjects
The ‘Healthy Growth Study’ was a cross-sectional epidemiological study
initiated in May 2007. Approval to conduct the study was granted by the
Greek Ministry of National Education (7055/C7-Athens, 19-01-2007) and the
Ethics Committee of Harokopio University of Athens (16/Athens, 19-12-2006).
The study population comprised school children attending the fifth and sixth
grades of primary schools located in the regions of Attica, Etoloakarnania,
Thessaloniki and Heraklion. The sampling procedure is fully described
elsewhere.15 For the purpose of the current analysis, a subsample of
24 obese and 23 normal-weight preadolescent girls, as well as 11 obese and
11 normal-weight preadolescent boys (Table 1) was selected. This subsample
was initially used to investigate the effect of polymorphism in the FTO gene on
genome-wide DNA methylation patterns.16
Dietary assessment
Dietary intake data was obtained for two consecutive weekdays and one
weekend day, via morning interviews with the children at the school site using
the 24-h recall technique. More specifically, all study participants were asked to
describe the type and amount of foods and beverages consumed during the
previous day, provided that it was a usual day according to the participant’s
perception. To improve the accuracy of food descriptions, standard household
measures (cups, tablespoons, etc) and food models were used to define
amounts. At the end of each interview, the interviewers, who were dietitians
rigorously trained to minimize interviewer’s effect, reviewed the collected food
intake data with the respondent to clarify entries, servings and possible
forgotten foods. Food intake data were analyzed using the Nutritionist V diet
analysis software (version 2.1, 1999, First Databank, San Bruno, CA, USA),
which was extensively amended to include traditional Greek recipes, as
described in Food Composition Tables of Greek Cooked Foods and Dishes.
Furthermore, the database was updated with nutritional information of
processed foods provided by independent research institutes, food companies
and fast-food chains.
Table 1 Demographic data stratified for weight category and gender
Gender Normal-weight Obese P-valuea
Male
N 11 11
Age (years) 10.34±0.25 10.82±0.56 0.03
Height (z-score)b 1.0±0.20 0.44±0.21 o0.001
Weight (z-score)b 0.94±0.093 1.5±0.15 o0.001
BMI (z-score)b 0.71±0.11 1.6±0.19 o0.001
White blood cell count (103/mm3) 8.56±3.85 6.93±1.27 n.s.
Tanner stagec (z-score)b 1.5±0.27 1.5±0.32 n.s.
Total fat intake (% of total energy intake) 39.92±8.96 45.82±9.54 n.s.
MUFA intake (% of total energy intake) 19.00±5.97 21.74±5.91 n.s.
PUFA intake (% of total energy intake) 7.83±7.99 4.77±0.92 n.s.
SFA intake (% of total energy intake) 13.32±3.62 16.29±3.54 n.s.
Cholesterol (g/day) 188.90±101.84 304.49±137.54 n.s.
Female
N 23 24
Age (years) 10.54±0.46 10.94±0.71 0.05
Height (z-score)b 0.76±0.16 0.30±0.24 0.001
Weight (z-score)b 0.86±0.088 1.5±0.19 o0.001
BMI (z-score)b 0.72±0.079 1.8±0.13 o0.001
White blood cell count (103/mm3) 7.26±2.07 7.28±1.70 n.s.
Tanner stagec (z-score)b 1.45±0.14 0.70±0.21 n.s.
Total fat intake (% of total energy intake) 42.22±6.59 38.42±7.66 n.s.
MUFA intake (% of total energy intake) 18.83±4.85 17.96±±5.15 n.s.
PUFA intake (% of total energy intake) 7.56±11.42 4.30±2.13 0.04
SFA intake (% of total energy intake) 15.55±2.98 13.67±4.28 0.04
Cholesterol (g/day) 216.25±89.86 211.04±125.58 n.s.
Abbreviations: BMI, body mass index; MUFA, monounsaturated fatty acid; n.s., nonsignificant; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid.
aIndicates P-value for significant or n.s. differences between obese and normal-weight individuals. All values are means±SEs.
bz-Scores were calculated using all samples from the Healthy Growth Study as a reference population.
cDescribes pubertal development.
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DNA methylation profiling
The genome-wide Illumina Infinium HumanMethylation27 BeadChip
(Illumina, San Diego, CA, USA), which allows interrogation of 27 578 CpG
dinucleotides covering 14 495 genes was applied to determine the methylation
profile of genomic DNA isolated and purified from the peripheral whole
blood. This chip has been shown to give a reliable and reproducible estimation
of the methylation profile on a genomic scale.17 First, bisulfite conversion of
genomic DNAwas performed using the EZ DNA Methylation-Gold Kit (Zymo
Research, Irvine, CA, USA) according to the manufacturer’s protocol. Briefly,
500 ng of DNA was sodium bisulfite-treated, denatured at 98 1C for 10min,
and bisulfite converted at 64 1C for 2.5 h. After conversion, samples were
desulfonated and purified using column preparation. Approximately 200 ng of
bisulfate-converted DNA was processed according to the Illumina Infinium
Methylation Assay protocol. This assay is based on the conversion of
unmethylated cytosine (C) nucleotides into uracil/thymine (T) nucleotides
by the bisulfite treatment. The DNA was whole-genome amplified,
enzymatically fragmented, precipitated, resuspended, and hybridized
overnight at 48 1C to locus-specific oligonucleotide primers on the
BeadChip. After hybridization, the C or T nucleotides were detected by
single-base primer extension. The fluorescence signals corresponding to the
C or T nucleotides were measured from the BeadChips using the Illumina
iScan scanner. Phenotypes, raw data and background-corrected normalized
DNA methylation data are available through the GEO database (http://www.
ncbi.nlm.nih.gov/geo/) with accession numbers GSE27860 for the girls and
GSE57484 for the boys.
Data processing
All downstream data processing and statistical analyses were performed with
the statistical software R (www.r-project.org) together with the lumi,18 limma19
and IMA20 packages of the Bioconductor project.
Data preprocessing. The fluorescence data were preprocessed using the
GenomeStudio 2009.2 (Illumina) software. We used the log2 ratio of the
intensities of methylated probe versus unmethylated probe, also calledM-value,
which is more statistically valid for the differential analysis of methylation
levels.21
Quality control. The data were imported and submitted to quality control
using a modified version of the IMA.methy450PP function of the IMA package.
The following CpG sites and samples were removed: the sites with missing
b-values, the sites with detection P-value40.05, the sites having o75% of
samples with detection P-valueo105, the samples with missing b-values, the
samples with detection P-value4105 and the samples having o75% of sites
with detection P-valueo105. A total of 26 168 probes were included in the
analysis, after discarding 328 probes that did not reach the quality control
together with 1082 probes from the sex chromosomes.
Normalization. Quantile normalization was performed on the M-values of all
the 26 168 CpG sites using the lumiMethyN function of the lumi package.
Annotation. For better interpretation of the genome-wide methylation
patterns, we chose to use the expanded annotation table for the Illumina
Infinium HumanMethylation450 BeadChip array generated by Price et al.22
There are a total of 27 578 loci for 27k array, and 1600 of them are not mapped
to 450k array. For those unmapped loci, we kept their original annotation from
the 27k array. The expanded annotation file was used to determine the average
methylation value of CpG sites belonging to the same island or island shores
(all sites with the same name in the ‘HIL_CpG_Island_Name’ column of the
annotation file were averaged). We obtained the average methylation value of
5980 islands/island shores, which reduced the number of interrogated locations
to 19 437 sites/islands. The CpG island classification developed by Price et al22
provides good enrichment discrimination of CpG islands. This classification is
a combination of Weber et al’s classification23 where CpG islands are defined
according to the GC content, the Obs/Exp CpG ratio and the island length,
and Illumina’s classification, where CpG islands are defined according to their
physical position (islands, island shores, and shelves). The location within a
CpG island or shore are suggested to be relevant,24 and Price et al’s definition
of CpG islands allowed to distinguish different methylation distribution
between probes, which remained undetectable with the Illumina CpG island
classification.22 Besides, their classification demonstrated a more extreme DNA
methylation profile and a larger proportion of differentially methylated regions
between different tissues.
The expanded annotation file was also used to determine which gene each
interrogated CpG site/island may be associated with (‘Closest_TSS_
gene_name’ column of the annotation file), the distance of each interrogated
CpG site/island to the closest TSS (transcription start site) (‘Distance_
closest_TSS’ column of the annotation file) and the CpG density surrounding
each interrogated CpG site/island (‘HIL_CpG_class’ column of the annotation
file). Each site can either be located in a high-density CpG island, an
intermediate-density CpG island, a region of intermediate-density CpG island
that borders HCs, or a non-island. Indeed, the local CpG density has been
shown to influence the role of methylated cytosines, with methylation having
more transcriptional effect in high-density CpG island and less at non-
islands.25
The Illumina-provided MAPINFO GenomeStudio column was used to
determine the genomic location of each interrogated CpG site. For CpG
islands, the name of the island was used to determine its genomic location
(eg the island ‘chr19_IC:17905037-17906698’ would be a CpG island of
intermediate density located on chromosome 19, between 17 905 037 and
17 906 698).
Statistics
Linear model. We developed the following linear model for each CpG site k,
using limma’s robust regression method, with a maximum number of iteration
equal to 10 000:
Mk ¼ ak þ bkGGþ bkTTþ bkWW þ bkBBþ bkVV þ ek
where Mk is the M-value of CpG site/island k, G is the dichotomized gender
(female¼ 1 and male¼ 0), T is the Tanner stage, B is the white blood cell
count, W is the dichotomized weight category (normal-weight¼ 0 and
obese¼ 1), ek is the unexplained variability, and V is one of the following
variables: proportion of energy intake derived from total fat intake, cholesterol
intake (g/day), MUFA/SFA, PUFA/SFA, or (MUFAþPUFA)/SFA.
The coefficients bkx summarize the correlation between the methylation
level and the variables of interest. Moderated t-statistics for each contrast and
CpG site/island were created using an empirical Bayes model, to rank genes in
order of evidence for differential methylation.19 To control the proportion of
false positives, P-values were adjusted for multiple comparisons as proposed by
Benjamini and Hochberg (BH).26 An adjusted P-value40.05 was considered
nonsignificant.
Three children from the cohort had a MUFA/SFA, a PUFA/SFA, and a
(MUFAþPUFA)/SFA higher than the mean±3 SD. Thus, they were
excluded from the linear models developed for MUFA/SFA, PUFA/SFA, and
(MUFAþPUFA)/SFA.
Functional enrichment analysis. The unique Entrez Gene ID associated with
each significant gene-based site/island was identified. Three gene lists were
generated for MUFA/SFA, PUFA/SFA, and (MUFAþPUFA)/SFA, respectively.
We used the web-based ConsensusPathDB-human (CPDB)27,28 to
determine the significant pathways each gene list may be involved in.
On the basis of the reference gene set (all Entrez Gene IDs from the 27k
BeadChip annotation file were used as a background), the expected number of
genes in each pathway of the CPDB database is compared with the actual
number of genes found for this pathway. For each pathway, a P-value and a
q-value are calculated according to the hypergeometric test. The pathways with
a raw P-valueo0.05 together with a q-valueo0.05 were selected. As CPDB
includes information from 30 databases, the pathways often overlap with each
other to some extent. Thus, to show the relationships between the different
pathways, we constructed a heatmap of the proportion of shared input genes
between the significant pathways. For instance, if P1 is a given pathway
containing genes A, B, and C from the input gene list, and P2 is a given
pathway containing genes B, C, D, and E from the input gene list, the
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We also used the web-based g:Profiler29,30 as an alternative method for
pathway analysis, to confirm the significant results obtained with CPDB. The
g:GOSt tool was used for enrichment analysis, with the same background gene
list, and the g:GOSt native method g:SCS for multiple testing correction.
The pathways with an adjusted P-valueo0.05 were selected. It is important to
note that g:Profiler only includes pathways from two databases: KEGG and
Reactome.
RESULTS
Four CpG sites and one CpG island were found to be significantly
associated with the proportion of overall fat intake (Figure 1a), while
no significance was found for cholesterol intake. The methylation
levels of 2 islands, 11 island shores, and 16 sites were significantly
correlated with PUFA/SFA; 9 islands, 26 island shores, and 158 sites
for MUFA/SFA; 10 islands, 40 island shores, and 130 sites for
(MUFAþPUFA)/SFA (Figure 1b and Supplementary Tables 1–3).
What genes are associated with the significant CpG sites/islands?
To determine which gene may be regulated by each CpG site and
island, we identified the gene whose TSS is closest to each CpG site
and island. Each significant site, island or island shore can show either
Figure 1 Volcano plots for proportion of total energy intake derived from fat (a) and (MUFAþPUFA)/SFA (b). The regression coefficient refers to the
coefficient of the linear model and each point represents a CpG site or a CpG island. The red horizontal line is the significance threshold (P-value¼0.05)
and all points above this line are significant. (a) proportion of total energy intake derived from fat (positive coefficients refer to an increased methylation in
children for whom fat represents a higher proportion of total energy intake). (b) (MUFAþPUFA)/SFA (positive coefficients refer to an increased methylation
in children having a higher (MUFAþPUFA)/SFA).
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Table 2 Information on the significant CpG sites/island found for proportion of energy intake derived from fat and the top 10 most significant
CpG sites/islands found for MUFA/SFA, PUFA/SFA, and (MUFAþPUFA)/SFA
Gene
Entrez








Proportion of energy intake derived from fat
GPS1 2873 chr17:80009807 HC 80009 762 0.0135 0.00612
TAMM41 13 2001 chr3_HCshore:11887600_11888782;
chr3_ICshore:11887684_11888691
HC 11888 351 0.00987 0.00621
TAS2R13 50838 chr12:11061985 LC 11062 160 0.0118 0.0121
MZB1 51237 chr5:138725350 LC 138 725 604 0.0145 0.023
TXNIP 10628 chr1:145438031 IC 145 438 461 0.0148 0.043
MUFA/SFA
ALDH3A2 224 chr17:19552343 HC 19552 063 0.289 0.00097
MYLK3 91807 chr16:46782176 LC 46782 220 0.238 0.00363
LOC642852 257 103 chr21:46716835 LC 46707 966 0.317 0.00364
TPPP2 122 664 chr14:21498837 IC 21498 344 0.309 0.00364
RXFP2 122 042 chr13:32313824 NA 32313 679 0.262 0.00364
TMEM80 283 232 chr11_HCshore:694282_696564;
chr11_ICshore:694282_697179
HC 695 615 0.245 0.00364
SEMA3G 56920 chr3:52478874 HC 52479 042 0.28 0.00388
VCAM1 7412 chr1:101185020 LC 101 185 195 0.259 0.00482
KRT73 319 101 chr12:53013281 LC 53012 342 0.245 0.00496




HC 37442 284 1.28 4.02e–06
RBCK1 10616 chr20:388351 HC 388 708 0.687 2.3e–05
ABHD16A 7920 chr6_HCshore:31670422_31671462;
chr6_ICshore:31670279_31671902
HC 31671 136 0.302 7.18e–05
KRT23 25984 chr17:39095141 LC 39093 835 0.326 0.00536
PDE3A 5139 chr12_HCshore:20521268_20523183;
chr12_ICshore:20520944_20523341
HC 20522 178 0.274 0.0066
NCOA1 8648 chr2:24806720 LC 24807 344 0.42 0.00722
PCED1A 64773 chr20:2822804 LC 2 821 796 0.412 0.00914
MRPL13 27085 chr8:121457500 HC 121 457 646 0.308 0.0193
AKR7A2 54896 chr1_HCshore:19638013_19639253;
chr1_ICshore:19637904_19639606;
HC 19638 639 0.237 0.0193
FAM154A 158 297 chr9_IC:19032509_19033364 IC 19033 255 0.357 0.0193
(MUFAþPUFA)/SFA
MRPL13 27085 chr8:121457500 HC 121 457 646 0.186 0.000952
NCOA1 8648 chr2:24806720 LC 24807 344 0.233 0.00308
PCED1A 64773 chr20:2822804 LC 2821796 0.213 0.00308
CCNA2 890 chr4_HCshore:122744257_122745486;
chr4_ICshore:122744093_122745437
HC 122 745 087 0.126 0.00308
LCE1B 353 132 chr1:152783674 LC 152 784 446 0.254 0.00352
ALDH3A2 224 chr17:19552343 HC 19552 063 0.176 0.00352
MYLK3 91807 chr16:46782176 LC 46782 220 0.166 0.00352
GBP7 388 646 chr1:89641121 LC 89641 722 0.175 0.00352
DGKI 9162 chr7_HCshore:137530917_137532628;
chr7_ICshore:137530976_137532560
HC 137 531 608 0.178 0.00352
DNTTIP1 140 686 chr20:44421526 LC 44420 575 0.148 0.00561
Abbreviations: HC, high-density CpG island; IC, intermediate-density CpG island; LC, non-island; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid.
aCpG density surrounding each interrogated CpG site/island.
bValue of the coefficient of the linear model associated with (MUFAþPUFA)/SFA.
cP-value calculated by moderated t-statistics and adjusted for multiple comparisons according to Benjamini and Hochberg.
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a positive fold change if its methylation is higher in children having
an elevated dietary variable (eg, a higher cholesterol intake), or a
negative fold change if its methylation is lower in children having an
elevated dietary variable.
Regarding the proportion of fat intake, one CpG site associated
with taste receptor, type 2, member 13 (TAS2R13) that may have a
role in the perception of bitterness, while another site associated with
thioredoxin interacting protein (TXNIP), a regulator of cellular
oxidative stress downregulated by SFA uptake31 (Table 2).
The 10 most significant sites/islands/island shores found for
MUFA/SFA included one CpG site associated with aldehyde dehy-
drogenase 3 family, member A2 (ALDH3A2) (P¼ 0.00097), whose
expression is reduced in insulin-resistant murine models.32 It also
included a CpG site associated with sema domain, immunoglobulin
domain (Ig), short basic domain, secreted, (semaphorin) 3G
(SEMA3G) (P¼ 0.0039), whose expression increases during
adipogenesis.33 Among the top 10 found for PUFA/SFA, there was
1 CpG site associated with nuclear receptor coactivator 1 (NCOA1)
(P¼ 0.0072) and another 1 associated with PC-esterase domain
containing 1A (PCED1A) (P¼ 0.0091), as well as an island shore
associated with phosphodiesterase 3A, cGMP-inhibited (PDE3A)
(P¼ 0.0066; Table 2).
There were only 4 sites and 1 island shore found significant for all
fatty acid ratios, but 86 sites/islands/island shores in common
between MUFA/SFA and (MUFAþPUFA)/SFA, and 7 in common
between PUFA/SFA and (MUFAþPUFA)/SFA (Figure 2). Notably,
the four sites found significant for all fatty acid ratios contained some
of previously mentioned sites (Table 2), for example, the ones
associated with NCOA1 (P¼ 0.0031) (Figure 3a) and PCED1A
(P¼ 0.0031) (Figure 3b). It also included an island shore associated
with CCNA2 (Figure 3c), a gene recently shown to be associated with
serum phosphatidylcholine concentration in mice.34
In which pathways are the significant genes involved?
Instead of going through all the genes associated with the significant
sites found for MUFA/SFA, PUFA/SFA, and (MUFAþPUFA)/SFA, it
was preferred to perform a gene enrichment analysis. Using CPDP,27
we identified the significant pathways for each of the fatty acid ratios.
We considered a pathway significant if the significant CpG sites/
island/island shores were associated with a high proportion of genes
involved in this particular pathway.
Figure 2 Venn diagram of the significant CpG sites and islands found for
MUFA/SFA, PUFA/SFA, and (MUFAþPUFA)/SFA.
Figure 3 Correlation between methylation of three sites associated with
NCOA1 (a), PCED1A (b), CCNA2 (c), and (MUFAþPUFA)/SFA. Coeff
(coefficient) of the linear model associated with (MUFAþPUFA)/SFA; full
triangles, obese girls (n¼23); full circles, obese boys (n¼11); empty
triangles, normal-weight girls (n¼22); empty circles, normal-weight boys
(n¼10).
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Neither CPDB nor g:Profiler identified significant pathways for
MUFA/SFA, but CPDB found 34 significant pathways for PUFA/SFA
(Supplementary Table 4), including 1 group of pathways related to
adipogenesis and mechanism of gene regulation by peroxisome
proliferators via PPARa (Group 1, Figure 4a), and another group of
pathways related to leptin and IL6 (Group 2, Figure 4a). Five
significant pathways were identified for (MUFAþ PUFA)/SFA
using CPDB (Supplementary Table 4), including one group of
pathways linked to NF-kB (Group 1, Figure 4b). g:Profiler identified
only one significant pathway for (MUFAþPUFA)/SFA, also linked
to NF-kB (IKKb phosphorylates IkB causing NF-kB to dissociate,
P-value¼ 0.041).
DISCUSSION
In the present study of Greek preadolescents, we found a large
number of CpG sites and regions significantly associated with
variables related to the quality of fat intake and few sites significantly
associated with variables related to the quantity of fat intake.
Our findings suggest that fat quality is likely to influence DNA
methylation on a large genomic scale. NCOA1, one of the most
significant gene found for all fatty acids ratios, is involved in the
mechanism of gene regulation by peroxisome proliferators via PPARa,
a master gene whose regulation is altered in obesity.35 NCOA1 is a
transcriptional coactivator whose ablation confers susceptibility to
diet-induced obesity.36 Interestingly, various fatty acids, but especially
PUFAs, act as ligands for PPARa. Moreover, along with PDE3A, the
fifth most significant gene found for PUFA/SFA, NCOA1, is part of
the leptin pathway. Leptin is an adipokine that has a key role in
regulating energy intake by inhibiting the sensation of hunger.37 Fish
oil has been reported to increase plasma leptin concentrations,38 and
leptin induces the expression of NCOA1 in human cells.39 Besides,
PDE3A’s expression is enhanced in cows fed with a diet enriched in
fish oil or in SFA.40 Interestingly, an island shore located near the TSS
of PDE3A was less methylated in children with a higher PUFA/SFA.
All this information is consistent with the negative fold change
observed for NCOA1 in our cohort.
There was substantial overlap between the significant sites/islands/
island shores found for the different fatty acid ratios, but little overlap
between all fatty acid ratios. This may reflect how MUFA and PUFA
affect DNA methylation in a different way. Interestingly, the site
associated with NCOA1 was more significant for (MUFAþPUFA)/
SFA than for PUFA/SFA or MUFA/SFA, suggesting that PUFA and
MUFA affect the methylation of this gene in an identical way.
A similar observation can be made for PCED1A and CCNA2 that
were more significant for (MUFAþPUFA)/SFA than for PUFA/SFA
or MUFA/SFA. However, this may also be due to differences in power
to detect significant correlations, as the fatty acids ratios distributions
were quite different (Supplementary Figure 1).
It should be noted that two of the four individual CpG sites found
to be significantly associated with the proportion of energy intake
derived from fat might be relevant to obesity. It has been hypothesized
that individuals with increased bitter taste sensitivity avoid antiox-
idant-rich vegetables because of their perceived bitterness, consuming
instead sweet, fatty foods.41 The site associated with TAS2R13 was
more methylated in children for whom fat represents a higher
proportion of the total energy intake. In addition, children with a
higher proportion of energy intake derived from fat had a higher
methylation at a site located in an island shore near TXNIP, which is
consistent with the observed downregulation of TXNIP by SFA
uptake.31 None of these genes were previously reported to be
Figure 4 Heatmap representation of the proportion of shared genes between the significant pathways found for PUFA/SFA (a) and (MUFAþPUFA)/SFA (b).
Each significant pathway retrieved from CPDB (P-valueo0.05 and q-valueo0.05) is represented on the graph, along with the database it comes from.
A stronger color indicates a higher proportion of shared genes between two pathways. (a) Red rectangle 1: group of pathways related to adipogenesis and
mechanism of gene regulation by peroxisome proliferators via PPARa; red rectangle 2: group of pathways related to leptin and IL6. (b) Red rectangle 1:
group of pathways related to NF-kB. The full colour version of this figure is available at European Journal of Human Genetics online.
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differentially methylated depending on fat intake, probably because
the methylation assays of previous studies were limited in scope only
addressing key genes.
The present work was not devoid of limitations. First of all, our
sample size is limited (n¼ 69) and therefore replication is needed to
confirm our findings and to allow generalization to larger populations.
Second, the fatty acid ratios investigated herein are among the most
interesting to compare with respect to health, as their roles are heavily
debated and researched. However, other fatty acids not examined in
this study may reflect other aspects of the quality of fat intake. For
example, unsaturated fatty acids includes trans unsaturated fatty acids,
which have been demonstrated to have adverse effects on health.42 In
addition, we did not separate n-3 and n-6 PUFA in our study, but
these two fatty acids do not have the same effects; while both n-3 and
n-6 PUFA have beneficial effects, an excess of n-6 PUFA can cause
health disorders.43 DNA methylation was assessed in whole peripheral
blood, which is the case for most epigenetic studies focused on
nutrition, as peripheral changes may occur in relation to overall
energy balance.44 However, the methylation pattern observed in blood
may not always reflect the pattern in other tissues.45 The other
weakness of this approach is that DNA methylation can vary by blood
cell type, and thus the methylation changes associated with the
variables investigated in this study may represent an alteration in
blood cell composition, rather than a change in methylation. However,
no correlation was found between any of the investigated variables and
the relative proportions of granulocytes, lymphocytes, or mid cells
(P-value40.05 on Spearman’s correlation test). Finally, an increasing
number of human studies suggest that parental BMI impacts DNA
methylation in the offspring, especially at imprinted genes.46–48
However, evidences in humans are still scarce and limited to two
available tissues at birth: umbilical cord and/or placenta; thus, we did
not take parental BMI into account in our analysis.
In conclusion, this study is the first to demonstrate the roles of fat
quantity and quality in DNA methylation patterns at a genome-wide
scale. Our results suggest that specific changes in DNA methylation
may have an important role in the mechanisms involved in the
physiological responses to different types of dietary fat. Future studies
could reveal other potential impacts of dietary fat quality on DNA
methylation in controlled, randomized designs, and perhaps investi-
gate further the downstream effects of this process.
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